PET/CT in nononcological lung diseases: current applications and future perspectives
S Capitanio, AJ Nordin, AR Noraini… - European Respiratory …, 2016 - Eur Respiratory Soc
… This review article will focus on PET/CT applications in nononcological lung diseases. As …
the FDG-dominant group (FDG/Met uptake ratio ≥2) with respect to the Met-dominant group (…
the FDG-dominant group (FDG/Met uptake ratio ≥2) with respect to the Met-dominant group (…
Cell therapy for lung disease
S Geiger, D Hirsch, FG Hermann - European respiratory review, 2017 - Eur Respiratory Soc
… Although the aetiologies of various lung diseases are still … pulmonary disease) and aberrant
repair processes of lung … an attractive treatment option for lung diseases. This review focuses …
repair processes of lung … an attractive treatment option for lung diseases. This review focuses …
Quantitative computed tomography imaging of interstitial lung diseases
BJ Bartholmai, S Raghunath, RA Karwoski… - Journal of thoracic …, 2013 - journals.lww.com
… of interstitial lung disease. The HRCT features of some diseases can be diagnostic.
Longitudinal monitoring with HRCT can assess progression of interstitial lung disease; however, …
Longitudinal monitoring with HRCT can assess progression of interstitial lung disease; however, …
Pulmonary manifestations of acute lung injury: more than just diffuse alveolar damage
KT Hughes, MB Beasley - Archives of pathology & …, 2017 - meridian.allenpress.com
… lung disease that may present with a similar clinical presentation because this may impact
treatment decisions and disease … fibroblastic tissue should be the dominant finding in OP. As …
treatment decisions and disease … fibroblastic tissue should be the dominant finding in OP. As …
[PDF][PDF] Autopsy: a value to primordial and primary prevention for lung diseases
D Rana, N Kaushik, R Verma, R Pawar… - International Journal of …, 2022 - academia.edu
… Autopsies are necessary to establish cause of death of … lung lesions. Aims and objectives
were to identify the histopathological spectrum of lung disease and frequency of various lung …
were to identify the histopathological spectrum of lung disease and frequency of various lung …
Copa syndrome: a novel autosomal dominant immune dysregulatory disease
TJ Vece, LB Watkin, SK Nicholas, D Canter… - Journal of clinical …, 2016 - Springer
… kidney disease in pediatric patients that is caused by … is caused by immune dysregulation,
resulting in diffuse alveolar hemorrhage or interstitial lung disease, arthritis, and renal disease. …
resulting in diffuse alveolar hemorrhage or interstitial lung disease, arthritis, and renal disease. …
Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor
T Kitamura, N Tanaka, J Watanabe… - The Journal of …, 1999 - rupress.org
… We obtained BALF from 11 patients with I-PAP, 2 patients with S-PAP, 14 patients with
other lung diseases (3 cases each of sarcoidosis and collagen vascular lung disease; 2 cases …
other lung diseases (3 cases each of sarcoidosis and collagen vascular lung disease; 2 cases …
Diseases of the Small Airwaysl-3
… obstruction in chronic nonspecific lung disease. With such a … (40-42), implying that the lung
disease is associated with asystemic … Lung structure itself may play the dominant role in such …
disease is associated with asystemic … Lung structure itself may play the dominant role in such …
Epithelial–mesenchymal transition in lung development and disease: does it exist and is it important?
… Recent experimental data indicate that T helper 2 dominant chronic inflammation leads
to … In summary, we can say that the extent and significance of EMT in lung diseases is still …
to … In summary, we can say that the extent and significance of EMT in lung diseases is still …
Dominant and recessive oncogenes in the pathogenesis of lung cancer
JD Minna - Biology, toxicology, and carcinogenesis of respiratory …, 1990 - books.google.com
… disease, since there is a higher risk of lung cancer (p= 0.024) found in persons with chronic
obstructive pulmonary disease, of whom 8.8% develop lung cancer … lung disease. Clin. Res. …
obstructive pulmonary disease, of whom 8.8% develop lung cancer … lung disease. Clin. Res. …